HIV-1 resistance mechanism to an electrostatically constrained peptide fusion inhibitor that is active against T-20-resistant strains

about

Anti-HIV-1 activity determined by β-galactosidase activity in the multinuclear activation of an indicator assay is comparable with that by a conventional focus counting method.Mechanism of HIV-1 Resistance to an Electronically Constrained α-Helical Peptide Membrane Fusion Inhibitor.

P2860

Q40925666-0A14AB15-5D04-4309-9202-AFBAC77E023F Q47555768-AF351898-219D-4636-BBEC-8A888255EAA1

P2860

HIV-1 resistance mechanism to an electrostatically constrained peptide fusion inhibitor that is active against T-20-resistant strains

Item

http://www.wikidata.org/entity/Q37036508

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HIV-1 resistance mechanism to ...... against T-20-resistant strains

@en

HIV-1 resistance mechanism to ...... gainst T-20-resistant strains.

@nl

type

Item

label

HIV-1 resistance mechanism to ...... against T-20-resistant strains

@en

HIV-1 resistance mechanism to ...... gainst T-20-resistant strains.

@nl

prefLabel

HIV-1 resistance mechanism to ...... against T-20-resistant strains

@en

HIV-1 resistance mechanism to ...... gainst T-20-resistant strains.

@nl

P1476

HIV-1 resistance mechanism to ...... against T-20-resistant strains

@en

P2093

Fusako Miyamoto

http://www.w3.org/2001/XMLSchema#string

Kazuki Shimane

http://www.w3.org/2001/XMLSchema#string

Kentaro Watanabe

http://www.w3.org/2001/XMLSchema#string

Kumi Kawaji

http://www.w3.org/2001/XMLSchema#string

Mitsuo Kaku

http://www.w3.org/2001/XMLSchema#string

Nobutaka Fujii

http://www.w3.org/2001/XMLSchema#string

Yasuko Sakagami

http://www.w3.org/2001/XMLSchema#string

P2860

Potent D-peptide inhibitors of HIV-1 entry

Impact of the enfuvirtide resistance mutation N43D and the associated baseline polymorphism E137K on peptide sensitivity and six-helix bundle structure

X-ray crystallographic study of an HIV-1 fusion inhibitor with the gp41 S138A substitution

Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition

Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro.

Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design.

Resistance profiles of novel electrostatically constrained HIV-1 fusion inhibitors.

Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

P304

4035-4038

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00237-13

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23689710

http://www.w3.org/2001/XMLSchema#string

P932

3719727

http://www.w3.org/2001/XMLSchema#string

HIV-1 resistance mechanism to an electrostatically constrained peptide fusion inhibitor that is active against T-20-resistant strains

about

P2860

P2860

HIV-1 resistance mechanism to an electrostatically constrained peptide fusion inhibitor that is active against T-20-resistant strains

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932